Maybe we'll see on the flip side, you know, no, we are intricately involved with these people's, you know, progress and taking a lot of data, checking in constantly, and that goes a long way
The macro and the markets
MedVi Costs MedVi is fairly new in the GLP-1 marketplace Founded in 2024, MedVi is a telehealth platform that focuses exclusively on getting patients access to GLP-1 medications for weight loss, like compounded semaglutide and tirzepatide
Never share your pen , even with a new needle
Ibata K, Sun Q, Turrigiano GG
Tirzepatide's dual GIP/GLP-1 mechanism appears to dampen the brain's dopamine response to alcohol in the same reward pathway it suppresses for food